Virtual Reality Glass Use

June 18, 2026 updated by: Seyhan Çankaya, Selcuk University

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women With Premature Rupture of Membranes: A Randomized Controlled Trial

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women with Premature Rupture of Membranes: A Randomized Controlled Trial

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is a randomized controlled trial. The study population will consist of nulliparous pregnant women hospitalized with a diagnosis of preterm premature rupture of membranes (PPROM) in the Perinatology Clinic of Konya City Hospital between June 2025 and January 2027. A total of 176 pregnant women who will be giving birth for the first time will be included in the study (intervention group: n = 88; control group: n = 88). In the intervention group, pregnant women with PPROM will watch a nature-themed video accompanied by natural sounds selected by the researchers through a virtual reality headset (VRH) twice daily for three consecutive days, with each session lasting at least five minutes. The control group will receive the standard antenatal care provided by the hospital. Data will be collected using a Personal Information Form, the Fetal Health Anxiety Scale, the Prenatal Distress Questionnaire, and the Prenatal Attachment Inventory.

Study Type

Interventional

Enrollment (Estimated)

176

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
      • Konya, Turkey (Türkiye), 42250
        • Recruiting
        • Seyhan Çankaya
        • Contact:
        • Principal Investigator:
          • Seyhan Çankaya, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being 18 years of age or older
  • Being nulliparous
  • Having a diagnosis of preterm premature rupture of membranes (PPROM)
  • Being between 24 and 37 weeks of gestation
  • Having a singleton pregnancy
  • Being hospitalized in the ward for at least 3 days
  • Having no visual or hearing impairment
  • Being communicative and mentally and psychologically healthy
  • Being able to speak and express oneself in Turkish

Exclusion Criteria:

  • Having an additional diagnosis besides preterm premature rupture of membranes (PPROM) (e.g., preeclampsia, fetal distress, fetal anomalies, gestational diabetes, bleeding, etc.)
  • Having a chronic disease (e.g., hypertension, diabetes mellitus, thyroid disorders, etc.)
  • Having conceived through assisted reproductive technologies (ART)
  • Having any skin infection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Standard prenatal care

The control group will receive standard prenatal care and treatment provided by the hospital.

After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.
Other: Standard prenatal care

The control group will receive standard prenatal care and treatment provided by the hospital.

After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.

Other: Nature-themed video
Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.
Experimental: Nature-themed video
Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.
Other: Nature-themed video
Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of sociodemographic characteristics of pregnant women with premature rupture of membranes prior to intervention using questionnaires.
Time Frame: 6 months
Sociodemographic information of pregnant women will be collected, compared, and reported through questionnaires.
6 months
Comparison of mean scores on the Fetal Health Concern Scale among groups of pregnant women.
Time Frame: 6 months

The Fetal Health Concern Scale will be administered to pregnant women.

The Fetal Health Concern Scale ranges from 0 to 42 points (minimum-maximum), with higher scores indicating greater fetal health concern.
6 months
Comparison of mean Prenatal Distress Scale scores among groups of pregnant women.
Time Frame: 6 months

The Prenatal Distress Scale will be administered to all pregnant women.

The Prenatal Distress Scale ranges from 0 to 34 points (minimum-maximum), with higher scores indicating greater prenatal distress.
6 months
Comparison of mean Prenatal Attachment Inventory scores among groups of pregnant women.
Time Frame: 6 months

The Prenatal Attachment Inventory will be administered to all pregnant women.

The Prenatal Attachment Inventory score ranges from 21 to 84 points (minimum-maximum), with higher scores indicating greater prenatal distress.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Selcuk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 16, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

June 16, 2026

First Submitted That Met QC Criteria

June 18, 2026

First Posted (Actual)

June 22, 2026

Study Record Updates

Last Update Posted (Actual)

June 22, 2026

Last Update Submitted That Met QC Criteria

June 18, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2025/1150

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prenatal Attachment

Clinical Trials on Standard prenatal care

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe